In 2023, researchers at Baylor College of Medicine led by the late Dr. Bert O'Malley discovered that the steroid receptor ...

Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis ...

Researchers have uncovered a previously hidden “internal brake” on immune cells that limits their ability to fight cancer, ...

T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.

The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Bolyn Hubby, Ph.D., as Chief of Staff ...

Researchers have found that amlodipine, a calcium-channel blocker prescribed to tens of millions of people for high blood ...

Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...

A new treatment combining immunotherapy with chemotherapy after surgery cut the risk of cancer coming back and death by 50% ...

Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related adverse events remain a major concern.

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs.